SXTP
NASDAQ · Pharmaceuticals
60 Degrees Pharma Inc
$1.16
+0.12 (+11.54%)
Open$1.04
Previous Close$1.04
Day High$1.16
Day Low$1.04
52W High$8.62
52W Low$0.84
Volume—
Avg Volume89.3K
Market Cap3.36M
P/E Ratio—
EPS$-5.93
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+129.3% upside
Current
$1.16
$1.16
Target
$2.66
$2.66
$2.13
$2.66 avg
$3.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.39M | 5.27M | 862.6K |
| Net Income | -38,649,230 | -24,808,720 | 198.9K |
| Profit Margin | -522.7% | -496.6% | 23.1% |
| EBITDA | -40,486,504 | -27,431,837 | 334.7K |
| Free Cash Flow | — | — | 224.8K |
| Rev Growth | +40.2% | +40.2% | -6.7% |
| Debt/Equity | 0.04 | 0.04 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |